Powder: -20°C for 3 years | In solvent: -80°C for 1 year
KS370G (Caffeic Acid Phenethyl Amide) inhibits UUO-induced renal fibrosis marker expression. KS370G is an orally active hypoglycemic and cardioprotective agent that reduces collagen deposition in obstructed kidneys and significantly decreases renal expression of inflammatory chemokines/adhesion molecules and monocyte markers and improves left ventricular hypertrophy and function in the heart of pressure-overloaded mice.KS370G can be used to study renal obstructive nephropathy.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 16,000 | |||
5 mg | 在庫あり | ¥ 36,500 | |||
10 mg | 在庫あり | ¥ 53,500 | |||
25 mg | 在庫あり | ¥ 90,500 | |||
50 mg | 在庫あり | ¥ 134,500 | |||
100 mg | 在庫あり | ¥ 192,000 | |||
500 mg | 在庫あり | ¥ 388,000 |
説明 | KS370G (Caffeic Acid Phenethyl Amide) inhibits UUO-induced renal fibrosis marker expression. KS370G is an orally active hypoglycemic and cardioprotective agent that reduces collagen deposition in obstructed kidneys and significantly decreases renal expression of inflammatory chemokines/adhesion molecules and monocyte markers and improves left ventricular hypertrophy and function in the heart of pressure-overloaded mice.KS370G can be used to study renal obstructive nephropathy. |
ターゲット&IC50 | NO:0.44 μM(EC50) |
別名 | KS-370-G, KS 370 G, Caffeic Acid Phenethyl Amide |
分子量 | 283.32 |
分子式 | C17H17NO3 |
CAS No. | 105955-01-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (158.83 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
KS370G 105955-01-9 KS-370-G KS 370 G Caffeic Acid Phenethyl Amide Inhibitor inhibitor inhibit